Post-Ebola cataract surgery can safely restore vision
Cataract surgery can be safely performed on Ebola virus disease survivors with impaired vision, Emory Eye Center ophthalmologists and 40 colleagues around the world report.
Apr 4, 2018
0
9
Cataract surgery can be safely performed on Ebola virus disease survivors with impaired vision, Emory Eye Center ophthalmologists and 40 colleagues around the world report.
Apr 4, 2018
0
9
High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study published this week in PLOS Medicine by Jeremie Guedj of INSERM, France, and colleagues.
Mar 27, 2018
0
5
A new study comparing the effectiveness of individual ZMapp antibodies versus a cocktail of antibodies, administered to mice using recombinant adeno-associated virus (rAAV) delivery vectors, showed the ability to achieve ...
Mar 9, 2018
0
3
The effects of the Ebola virus disease (EVD) outbreak in 2014-2015 were felt not only directly, in the 28,616 cases of EVD and 11,310 deaths, but also indirectly, through the disruption in the provision of healthcare in Sierra ...
Feb 20, 2018
0
6
Ebola virus can infect the reproductive organs of male and female macaques, according to a study published in The American Journal of Pathology, suggesting that humans could be similarly infected. Prior studies of survivors ...
Feb 8, 2018
0
2
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...
Dec 14, 2017
0
9
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...
Nov 16, 2017
0
395
Scientists have identified a time lag of up to two years between forest loss and the emergence of Ebola virus disease along the limits of the West and Central African rainforest.
Nov 2, 2017
0
0
Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...
Oct 11, 2017
0
26
A new scientific study provides the first evidence-based assessment of pandemic potential in Africa prior to outbreaks and identifies ways to prevent them.
Oct 11, 2017
0
0